Concomitant Medications and Gastrointestinal Events in Thalassemia and MDS Patients Receiving Deferasirox for Transfusional Iron Overload: Data From the EPIC Study

被引：2
|
作者：
Cappellini, M. Domenica [1 ]
El-Beshlawy, Amal [2 ]
Porter, John B. [3 ]
Kattamis, Antonis [4 ]
Taylor, Kerry [5 ]
Rose, Christian [6 ]
Louw, Vernon J. [7 ]
El-Ali, Ali [8 ]
Martin, Nicolas [8 ]
Gattermann, Norbert [9 ]
机构：
[1] Univ Milan, Policlin Fdn IRCCS, Milan, Italy
[2] Cairo Univ, Cairo, Egypt
[3] UCL, London, England
[4] Univ Athens, Athens, Greece
[5] Mater Hosp, Brisbane, Qld, Australia
[6] Hop St Vincent de Paul, Lille, France
[7] Univ Free State, Bloemfontein, South Africa
[8] Novartis Pharma AG, Basel, Switzerland
[9] Univ Dusseldorf, D-40225 Dusseldorf, Germany
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.5182.5182
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5182
引用
收藏
页数：2
相关论文
共 50 条
  • [31] GEOGRAPHICAL DIFFERENCES IN IRON OVERLOAD AND IRON CHELATION PRACTICES IN ANEMIA PATIENTS: BASELINE RESULTS FROM THE TRANSFUSIONAL HEMOSIDEROSIS REGISTRY STUDY (TORS)
    Siritanaratkul, N.
    Lee, J. W.
    Pehlivan, M.
    Volodicheva, E.
    Jiang, Q.
    Grifi, F.
    Ko, B. S.
    Wong, R.
    Louw, V.
    Khelif, A.
    El-Ali, A.
    Losco, A.
    Ilhan, O.
    HAEMATOLOGICA, 2015, 100 : 782 - 783
  • [32] TREATMENT OF TRANSFUSIONAL IRON OVERLOAD IN PATIENTS WITH MYELODYSPLASTIC SYNDROME OR SEVERE ANEMIA: DATA FROM MULTI-CENTER CLINICAL PRACTICES
    Raptis, A.
    Duh, M. S.
    Wang, S. T.
    Dial, E.
    Fanourgiakis, I
    Fortner, B.
    Paley, C.
    Mody-Patel, N.
    Corral, M.
    Scott, J.
    VALUE IN HEALTH, 2009, 12 (03) : A132 - A132
  • [33] A Randomised 1 Year Study Evaluating the Impact of Vitamin C Supplementation on Systemic Iron Parameters of Iron Overload in Thalassemia Major Patients on Long-Term Treatment with Deferasirox
    Aydinok, Yesim
    Delebe, Metin
    Basol, Gunes
    Bayraktaroglu, Selen
    Karadas, Nihal
    Barutcuoglu, Burcu
    Sozmen, Eser
    Cabantchik, Zvi Ioav
    BLOOD, 2016, 128 (22)
  • [34] Deferasirox Compared With Deferoxamine For The Removal Of Cardiac Iron In Patients With β-Thalassemia Major: 2-Year Data From The Cordelia Extension
    Pennell, Dudley J.
    Porter, John B.
    Piga, Antonio
    Lai, Yongrong
    El-Beshlawy, Amal
    Belhoul, Khawla
    Elalfy, Mohsen
    Yesilipek, Akif
    Kilinc, Yurdanur
    Wegener, Antje
    Habr, Dany
    Shen, Junwu
    Aydinok, Yesim
    BLOOD, 2013, 122 (21)
  • [35] Efficacy and Safety of Deferasirox (Exjade®) in β-Thalassemia Patients with Myocardial Siderosis: 2-Year Results From the EPIC Cardiac Sub-Study
    Pennell, Dudley J.
    Porter, John B.
    Cappellini, M. Domenica
    Chan, Lee Lee
    El-Beshlawy, Amal
    Aydinok, Yesim
    Ibrahim, Hishamshah
    Li, Chi-Kong
    Viprakasit, Vip
    Elalfy, Mohsen Saleh
    Kattamis, Antonis
    Smith, Gillian
    Habr, Dany
    Domokos, Gabor
    Roubert, Bernard
    Taher, Ali
    BLOOD, 2009, 114 (22) : 1558 - 1558
  • [36] A Multi-Center, Open Label Study Evaluating the Efficacy of Iron Chelation Therapy with Deferasirox in Transfusional Iron Overload Patients with Myelodysplastic Syndromes or Aplastic Anemia Using Quantitative R2 MRI
    Min, Yoo-Hong
    Kim, Hyeoung Joon
    Lee, Kyoo Hyung
    Yoon, Sung-Soo
    Lee, Jae Hoon
    Park, Hee-Sook
    Kim, Jin Seok
    Kim, Ho Young
    Shim, Hyeok
    Seong, Chu-Myong
    Kim, Chul Soo
    Chung, Jooseop
    Hyun, Myung Soo
    Jo, Deog-Yeon
    Jung, Chul Won
    Sohn, Sang Kyun
    Yoon, Hwi-Jong
    Kim, Byung Soo
    Joo, Young-Don
    Park, Chi-Young
    Cheong, June-Won
    BLOOD, 2008, 112 (11) : 1249 - 1249
  • [37] A Multi-Center, Open Label Study Evaluating the Efficacy, of Iron Chelation Therapy with Deferasirox In Transfusional Iron Overload Patients with Myelodysplastic Syndromes or Aplastic Anemia Using Quantitative R2 mri
    Min, Yoo-Hong
    Kim, Hyeoung Joon
    Lee, Kyoo-Hyung
    Lee, Jae Hoon
    Park, Hee-Sook
    Kim, Jin Seok
    Shim, Hyeok
    Seung, Chu-Myung
    Kim, Chul Soo
    Chung, Jooseop
    Hyun, Myung Soo
    Jo, Deog-Yeon
    Jung, Chul Won
    Sohn, Sang Kyun
    Yoon, Hwi-Joong
    Kim, Byung Soo
    Joo, Young-Don
    Park, Chi-Young
    BLOOD, 2010, 116 (21) : 489 - 489
  • [38] A multi-center, open label study evaluating the efficacy of iron chelation therapy with deferasirox in transfusional iron overload patients with myelodysplastic syndromes or aplastic anemia using quantitative R2 MRI
    Min, Y.
    Cheong, J.
    Kim, H.
    Lee, K.
    Yoon, S.
    Lee, J.
    Park, H.
    Kim, H.
    Shim, H.
    Seung, C.
    Kim, C.
    Chung, J.
    Hyun, M.
    Jo, D.
    Jung, C.
    LEUKEMIA RESEARCH, 2009, 33 : S118 - S119
  • [39] Prevalence and predictors of cardiac and liver iron overload in patients with thalassemia: A multicenter study based on real-world data
    Krittayaphong, Rungroj
    Viprakasit, Vip
    Saiviroonporn, Pairash
    Siritanaratkul, Noppadol
    Siripornpitak, Suvipaporn
    Meekaewkunchorn, Arunotai
    Kirawittaya, Thawatchai
    Sripornsawan, Pornpun
    Jetsrisuparb, Arunee
    Srinakarin, Jiraporn
    Wong, Peerapon
    Phalakornkul, Nuttaporntira
    Sinlapamongkolkul, Phakatip
    Wood, John
    BLOOD CELLS MOLECULES AND DISEASES, 2017, 66 : 24 - 30
  • [40] BIO-MARKERS OF IRON TRAFFICKING AND DISTRIBUTION IN TRANSFUSIONAL OVERLOAD: INSIGHTS FROM COMPARING DIOND BLACKFAN ANEMIA WITH SICKLE CELL DISEASE AND THALASSEMIA (MCSIO PILOT STUDY)
    Porter, John
    Walter, Patrick
    Neumayr, Lynne
    Evans, Patricia
    Weyhmiller, Marcela
    Harmatz, Paul
    Wood, John
    Miller, Jeff
    Weiss, Guenter
    Yuan, Quing
    Wang, Zhiyue
    Grosse, Regine
    Schoennagel, Bjoern
    Meerpohl, Joerg
    Fischer, Roland
    Nielsen, Peter
    Seifert, Markus
    Vichinsky, Elliott
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (05) : E46 - E47
12345